What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global IVD Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publish Date: Feb, 2020
Report ID: 410734
Category: Pharmaceuticals and Healthcare
Pages: 109

$3480

Market Overview

The global IVD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 7996.1 million by 2025, from USD 7229.9 million in 2019.

The IVD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

IVD market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, IVD market has been segmented into:

Immuno Diagnostics

Chemistry Diagnostics

Molecular Diagnostics

POCT

Other

By Application, IVD has been segmented into:

Diabetes

Infectious Diseases

Oncology/Cancer

Cardiology

Nephrology

Autoimmune Diseases

Drug Testing/Pharmacogenomics

HIV/AIDS

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global IVD market presented in the report. This section sheds light on the sales growth of different regional and country-level IVD markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global IVD market.

The report offers in-depth assessment of the growth and other aspects of the IVD market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and IVD Market Share Analysis

IVD competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, IVD sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the IVD sales, revenue and market share for each player covered in this report.

The major players covered in IVD are:

Roche Diagnostics

BiomÃ©rieux Sa

Siemens

Danaher Corporation

Becton, Dickinson and Company

Abbott Laboratories

Johnson & Johnson

Thermo Fisher Scientific

Sysmex

Bio-Rad Laboratories

Agilent Technologies

Ortho Clinical Diagnostics

Qiagen

Diasorin

Request Sample Request for Customization

Table of Contents

1 IVD Market Overview

1.1 Product Overview and Scope of IVD

1.2 Classification of IVD by Type

1.2.1 Global IVD Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global IVD Revenue Market Share by Type in 2019

1.2.3 Immuno Diagnostics

1.2.4 Chemistry Diagnostics

1.2.5 Molecular Diagnostics

1.2.6 POCT

1.2.7 Other

1.3 Global IVD Market by Application

1.3.1 Overview: Global IVD Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Diabetes

1.3.3 Infectious Diseases

1.3.4 Oncology/Cancer

1.3.5 Cardiology

1.3.6 Nephrology

1.3.7 Autoimmune Diseases

1.3.8 Drug Testing/Pharmacogenomics

1.3.9 HIV/AIDS

1.3.10 Others

1.4 Global IVD Market by Regions

1.4.1 Global IVD Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of IVD (2015-2025)

1.4.3 North America (USA, Canada and Mexico) IVD Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) IVD Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IVD Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) IVD Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IVD Status and Prospect (2015-2025)

2 Company Profiles

2.1 Roche Diagnostics

2.1.1 Roche Diagnostics Details

2.1.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Roche Diagnostics SWOT Analysis

2.1.4 Roche Diagnostics Product and Services

2.1.5 Roche Diagnostics IVD Revenue, Gross Margin and Market Share (2018-2019)

2.2 BiomÃ©rieux Sa

2.2.1 BiomÃ©rieux Sa Details

2.2.2 BiomÃ©rieux Sa Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 BiomÃ©rieux Sa SWOT Analysis

2.2.4 BiomÃ©rieux Sa Product and Services

2.2.5 BiomÃ©rieux Sa IVD Revenue, Gross Margin and Market Share (2018-2019)

2.3 Siemens

2.3.1 Siemens Details

2.3.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Siemens SWOT Analysis

2.3.4 Siemens Product and Services

2.3.5 Siemens IVD Revenue, Gross Margin and Market Share (2018-2019)

2.4 Danaher Corporation

2.4.1 Danaher Corporation Details

2.4.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Danaher Corporation SWOT Analysis

2.4.4 Danaher Corporation Product and Services

2.4.5 Danaher Corporation IVD Revenue, Gross Margin and Market Share (2018-2019)

2.5 Becton, Dickinson and Company

2.5.1 Becton, Dickinson and Company Details

2.5.2 Becton, Dickinson and Company Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Becton, Dickinson and Company SWOT Analysis

2.5.4 Becton, Dickinson and Company Product and Services

2.5.5 Becton, Dickinson and Company IVD Revenue, Gross Margin and Market Share (2018-2019)

2.6 Abbott Laboratories

2.6.1 Abbott Laboratories Details

2.6.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Abbott Laboratories SWOT Analysis

2.6.4 Abbott Laboratories Product and Services

2.6.5 Abbott Laboratories IVD Revenue, Gross Margin and Market Share (2018-2019)

2.7 Johnson & Johnson

2.7.1 Johnson & Johnson Details

2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Johnson & Johnson SWOT Analysis

2.7.4 Johnson & Johnson Product and Services

2.7.5 Johnson & Johnson IVD Revenue, Gross Margin and Market Share (2018-2019)

2.8 Thermo Fisher Scientific

2.8.1 Thermo Fisher Scientific Details

2.8.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Thermo Fisher Scientific SWOT Analysis

2.8.4 Thermo Fisher Scientific Product and Services

2.8.5 Thermo Fisher Scientific IVD Revenue, Gross Margin and Market Share (2018-2019)

2.9 Sysmex

2.9.1 Sysmex Details

2.9.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Sysmex SWOT Analysis

2.9.4 Sysmex Product and Services

2.9.5 Sysmex IVD Revenue, Gross Margin and Market Share (2018-2019)

2.10 Bio-Rad Laboratories

2.10.1 Bio-Rad Laboratories Details

2.10.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Bio-Rad Laboratories SWOT Analysis

2.10.4 Bio-Rad Laboratories Product and Services

2.10.5 Bio-Rad Laboratories IVD Revenue, Gross Margin and Market Share (2018-2019)

2.11 Agilent Technologies

2.11.1 Agilent Technologies Details

2.11.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Agilent Technologies SWOT Analysis

2.11.4 Agilent Technologies Product and Services

2.11.5 Agilent Technologies IVD Revenue, Gross Margin and Market Share (2018-2019)

2.12 Ortho Clinical Diagnostics

2.12.1 Ortho Clinical Diagnostics Details

2.12.2 Ortho Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Ortho Clinical Diagnostics SWOT Analysis

2.12.4 Ortho Clinical Diagnostics Product and Services

2.12.5 Ortho Clinical Diagnostics IVD Revenue, Gross Margin and Market Share (2018-2019)

2.13 Qiagen

2.13.1 Qiagen Details

2.13.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Qiagen SWOT Analysis

2.13.4 Qiagen Product and Services

2.13.5 Qiagen IVD Revenue, Gross Margin and Market Share (2018-2019)

2.14 Diasorin

2.14.1 Diasorin Details

2.14.2 Diasorin Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Diasorin SWOT Analysis

2.14.4 Diasorin Product and Services

2.14.5 Diasorin IVD Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global IVD Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 IVD Players Market Share

3.2.2 Top 10 IVD Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global IVD Revenue and Market Share by Regions

4.2 North America IVD Revenue and Growth Rate (2015-2020)

4.3 Europe IVD Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific IVD Revenue and Growth Rate (2015-2020)

4.5 South America IVD Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa IVD Revenue and Growth Rate (2015-2020)

5 North America IVD Revenue by Countries

5.1 North America IVD Revenue by Countries (2015-2020)

5.2 USA IVD Revenue and Growth Rate (2015-2020)

5.3 Canada IVD Revenue and Growth Rate (2015-2020)

5.4 Mexico IVD Revenue and Growth Rate (2015-2020)

6 Europe IVD Revenue by Countries

6.1 Europe IVD Revenue by Countries (2015-2020)

6.2 Germany IVD Revenue and Growth Rate (2015-2020)

6.3 UK IVD Revenue and Growth Rate (2015-2020)

6.4 France IVD Revenue and Growth Rate (2015-2020)

6.5 Russia IVD Revenue and Growth Rate (2015-2020)

6.6 Italy IVD Revenue and Growth Rate (2015-2020)

7 Asia-Pacific IVD Revenue by Countries

7.1 Asia-Pacific IVD Revenue by Countries (2015-2020)

7.2 China IVD Revenue and Growth Rate (2015-2020)

7.3 Japan IVD Revenue and Growth Rate (2015-2020)

7.4 Korea IVD Revenue and Growth Rate (2015-2020)

7.5 India IVD Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia IVD Revenue and Growth Rate (2015-2020)

8 South America IVD Revenue by Countries

8.1 South America IVD Revenue by Countries (2015-2020)

8.2 Brazil IVD Revenue and Growth Rate (2015-2020)

8.3 Argentina IVD Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue IVD by Countries

9.1 Middle East & Africa IVD Revenue by Countries (2015-2020)

9.2 Saudi Arabia IVD Revenue and Growth Rate (2015-2020)

9.3 UAE IVD Revenue and Growth Rate (2015-2020)

9.4 Egypt IVD Revenue and Growth Rate (2015-2020)

9.5 South Africa IVD Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global IVD Revenue and Market Share by Type (2015-2020)

10.2 Global IVD Market Forecast by Type (2019-2024)

10.3 Immuno Diagnostics Revenue Growth Rate (2015-2025)

10.4 Chemistry Diagnostics Revenue Growth Rate (2015-2025)

10.5 Molecular Diagnostics Revenue Growth Rate (2015-2025)

10.6 POCT Revenue Growth Rate (2015-2025)

10.7 Other Revenue Growth Rate (2015-2025)

11 Global IVD Market Segment by Application

11.1 Global IVD Revenue Market Share by Application (2015-2020)

11.2 IVD Market Forecast by Application (2019-2024)

11.3 Diabetes Revenue Growth (2015-2020)

11.4 Infectious Diseases Revenue Growth (2015-2020)

11.5 Oncology/Cancer Revenue Growth (2015-2020)

11.6 Cardiology Revenue Growth (2015-2020)

11.7 Nephrology Revenue Growth (2015-2020)

11.8 Autoimmune Diseases Revenue Growth (2015-2020)

11.9 Drug Testing/Pharmacogenomics Revenue Growth (2015-2020)

11.10 HIV/AIDS Revenue Growth (2015-2020)

11.11 Others Revenue Growth (2015-2020)

12 Global IVD Market Size Forecast (2021-2025)

12.1 Global IVD Market Size Forecast (2021-2025)

12.2 Global IVD Market Forecast by Regions (2021-2025)

12.3 North America IVD Revenue Market Forecast (2021-2025)

12.4 Europe IVD Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific IVD Revenue Market Forecast (2021-2025)

12.6 South America IVD Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa IVD Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global IVD Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of IVD by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global IVD Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market IVD Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Roche Diagnostics Corporate Information, Location and Competitors

Table 6. Roche Diagnostics IVD Major Business

Table 7. Roche Diagnostics IVD Total Revenue (USD Million) (2017-2018)

Table 8. Roche Diagnostics SWOT Analysis

Table 9. Roche Diagnostics IVD Product and Solutions

Table 10. Roche Diagnostics IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 11. BiomÃ©rieux Sa Corporate Information, Location and Competitors

Table 12. BiomÃ©rieux Sa IVD Major Business

Table 13. BiomÃ©rieux Sa IVD Total Revenue (USD Million) (2018-2019)

Table 14. BiomÃ©rieux Sa SWOT Analysis

Table 15. BiomÃ©rieux Sa IVD Product and Solutions

Table 16. BiomÃ©rieux Sa IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 17. Siemens Corporate Information, Location and Competitors

Table 18. Siemens IVD Major Business

Table 19. Siemens IVD Total Revenue (USD Million) (2017-2018)

Table 20. Siemens SWOT Analysis

Table 21. Siemens IVD Product and Solutions

Table 22. Siemens IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 23. Danaher Corporation Corporate Information, Location and Competitors

Table 24. Danaher Corporation IVD Major Business

Table 25. Danaher Corporation IVD Total Revenue (USD Million) (2017-2018)

Table 26. Danaher Corporation SWOT Analysis

Table 27. Danaher Corporation IVD Product and Solutions

Table 28. Danaher Corporation IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 29. Becton, Dickinson and Company Corporate Information, Location and Competitors

Table 30. Becton, Dickinson and Company IVD Major Business

Table 31. Becton, Dickinson and Company IVD Total Revenue (USD Million) (2017-2018)

Table 32. Becton, Dickinson and Company SWOT Analysis

Table 33. Becton, Dickinson and Company IVD Product and Solutions

Table 34. Becton, Dickinson and Company IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 35. Abbott Laboratories Corporate Information, Location and Competitors

Table 36. Abbott Laboratories IVD Major Business

Table 37. Abbott Laboratories IVD Total Revenue (USD Million) (2017-2018)

Table 38. Abbott Laboratories SWOT Analysis

Table 39. Abbott Laboratories IVD Product and Solutions

Table 40. Abbott Laboratories IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 41. Johnson & Johnson Corporate Information, Location and Competitors

Table 42. Johnson & Johnson IVD Major Business

Table 43. Johnson & Johnson IVD Total Revenue (USD Million) (2017-2018)

Table 44. Johnson & Johnson SWOT Analysis

Table 45. Johnson & Johnson IVD Product and Solutions

Table 46. Johnson & Johnson IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 47. Thermo Fisher Scientific Corporate Information, Location and Competitors

Table 48. Thermo Fisher Scientific IVD Major Business

Table 49. Thermo Fisher Scientific IVD Total Revenue (USD Million) (2017-2018)

Table 50. Thermo Fisher Scientific SWOT Analysis

Table 51. Thermo Fisher Scientific IVD Product and Solutions

Table 52. Thermo Fisher Scientific IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 53. Sysmex Corporate Information, Location and Competitors

Table 54. Sysmex IVD Major Business

Table 55. Sysmex IVD Total Revenue (USD Million) (2017-2018)

Table 56. Sysmex SWOT Analysis

Table 57. Sysmex IVD Product and Solutions

Table 58. Sysmex IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 59. Bio-Rad Laboratories Corporate Information, Location and Competitors

Table 60. Bio-Rad Laboratories IVD Major Business

Table 61. Bio-Rad Laboratories IVD Total Revenue (USD Million) (2017-2018)

Table 62. Bio-Rad Laboratories SWOT Analysis

Table 63. Bio-Rad Laboratories IVD Product and Solutions

Table 64. Bio-Rad Laboratories IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 65. Agilent Technologies Corporate Information, Location and Competitors

Table 66. Agilent Technologies IVD Major Business

Table 67. Agilent Technologies IVD Total Revenue (USD Million) (2017-2018)

Table 68. Agilent Technologies SWOT Analysis

Table 69. Agilent Technologies IVD Product and Solutions

Table 70. Agilent Technologies IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 71. Ortho Clinical Diagnostics Corporate Information, Location and Competitors

Table 72. Ortho Clinical Diagnostics IVD Major Business

Table 73. Ortho Clinical Diagnostics IVD Total Revenue (USD Million) (2017-2018)

Table 74. Ortho Clinical Diagnostics SWOT Analysis

Table 75. Ortho Clinical Diagnostics IVD Product and Solutions

Table 76. Ortho Clinical Diagnostics IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 77. Qiagen Corporate Information, Location and Competitors

Table 78. Qiagen IVD Major Business

Table 79. Qiagen IVD Total Revenue (USD Million) (2017-2018)

Table 80. Qiagen SWOT Analysis

Table 81. Qiagen IVD Product and Solutions

Table 82. Qiagen IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 83. Diasorin Corporate Information, Location and Competitors

Table 84. Diasorin IVD Major Business

Table 85. Diasorin IVD Total Revenue (USD Million) (2017-2018)

Table 86. Diasorin SWOT Analysis

Table 87. Diasorin IVD Product and Solutions

Table 88. Diasorin IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 89. Global IVD Revenue (Million USD) by Players (2015-2020)

Table 90. Global IVD Revenue Share by Players (2015-2020)

Table 91. Global IVD Revenue (Million USD) by Regions (2015-2020)

Table 92. Global IVD Revenue Market Share by Regions (2015-2020)

Table 93. North America IVD Revenue by Countries (2015-2020)

Table 94. North America IVD Revenue Market Share by Countries (2015-2020)

Table 95. Europe IVD Revenue (Million USD) by Countries (2015-2020)

Table 96. Asia-Pacific IVD Revenue (Million USD) by Countries (2015-2020)

Table 97. South America IVD Revenue by Countries (2015-2020)

Table 98. South America IVD Revenue Market Share by Countries (2015-2020)

Table 99. Middle East and Africa IVD Revenue (Million USD) by Countries (2015-2020)

Table 100. Middle East and Africa IVD Revenue Market Share by Countries (2015-2020)

Table 101. Global IVD Revenue (Million USD) by Type (2015-2020)

Table 102. Global IVD Revenue Share by Type (2015-2020)

Table 103. Global IVD Revenue Forecast by Type (2021-2025)

Table 104. Global IVD Revenue by Application (2015-2020)

Table 105. Global IVD Revenue Share by Application (2015-2020)

Table 106. Global IVD Revenue Forecast by Application (2021-2025)

Table 107. Global IVD Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. IVD Picture

Figure 2. Global IVD Revenue Market Share by Type in 2019

Figure 3. Immuno Diagnostics Picture

Figure 4. Chemistry Diagnostics Picture

Figure 5. Molecular Diagnostics Picture

Figure 6. POCT Picture

Figure 7. Other Picture

Figure 8. IVD Revenue Market Share by Application in 2019

Figure 9. Diabetes Picture

Figure 10. Infectious Diseases Picture

Figure 11. Oncology/Cancer Picture

Figure 12. Cardiology Picture

Figure 13. Nephrology Picture

Figure 14. Autoimmune Diseases Picture

Figure 15. Drug Testing/Pharmacogenomics Picture

Figure 16. HIV/AIDS Picture

Figure 17. Others Picture

Figure 18. Global IVD Revenue (USD Million) and Growth Rate (2015-2025)

Figure 19. North America IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 20. Europe IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 21. Asia-Pacific IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 22. South America IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 23. Middle East and Africa IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 24. Global IVD Revenue (Million USD) and Growth Rate (2015-2025)

Figure 25. Global IVD Revenue Share by Players in 2019

Figure 26. Global Top 5 Players IVD Revenue Market Share in 2019

Figure 27. Global Top 10 Players IVD Revenue Market Share in 2019

Figure 28. Key Players Market Share Trend

Figure 29. Global IVD Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 30. Global IVD Revenue Market Share by Regions (2015-2020)

Figure 31. Global IVD Revenue Market Share by Regions in 2018

Figure 32. North America IVD Revenue and Growth Rate (2015-2020)

Figure 33. Europe IVD Revenue and Growth Rate (2015-2020)

Figure 34. Asia-Pacific IVD Revenue and Growth Rate (2015-2020)

Figure 35. South America IVD Revenue and Growth Rate (2015-2020)

Figure 36. Middle East and Africa IVD Revenue and Growth Rate (2015-2020)

Figure 37. North America IVD Revenue Market Share by Countries (2015-2020)

Figure 38. North America IVD Revenue Market Share by Countries in 2019

Figure 39. USA IVD Revenue and Growth Rate (2015-2020)

Figure 40. Canada IVD Revenue and Growth Rate (2015-2020)

Figure 41. Mexico IVD Revenue and Growth Rate (2015-2020)

Figure 42. Europe IVD Revenue Market Share by Countries (2015-2020)

Figure 43. Europe IVD Revenue Market Share by Countries in 2019

Figure 44. Germany IVD Revenue and Growth Rate (2015-2020)

Figure 45. UK IVD Revenue and Growth Rate (2015-2020)

Figure 46. France IVD Revenue and Growth Rate (2015-2020)

Figure 47. Russia IVD Revenue and Growth Rate (2015-2020)

Figure 48. Italy IVD Revenue and Growth Rate (2015-2020)

Figure 49. Asia-Pacific IVD Revenue Market Share by Countries (2015-2020)

Figure 50. Asia-Pacific IVD Revenue Market Share by Countries in 2019

Figure 51. China IVD Revenue and Growth Rate (2015-2020)

Figure 52. Japan IVD Revenue and Growth Rate (2015-2020)

Figure 53. Korea IVD Revenue and Growth Rate (2015-2020)

Figure 54. India IVD Revenue and Growth Rate (2015-2020)

Figure 55. Southeast Asia IVD Revenue and Growth Rate (2015-2020)

Figure 56. South America IVD Revenue Market Share by Countries (2015-2020)

Figure 57. South America IVD Revenue Market Share by Countries in 2019

Figure 58. Brazil IVD Revenue and Growth Rate (2015-2020)

Figure 59. Argentina IVD Revenue and Growth Rate (2015-2020)

Figure 60. Middle East and Africa IVD Revenue Market Share by Countries (2015-2020)

Figure 61. Middle East and Africa IVD Revenue Market Share by Countries in 2019

Figure 62. Saudi Arabia IVD Revenue and Growth Rate (2015-2020)

Figure 63. UAE IVD Revenue and Growth Rate (2015-2020)

Figure 64. Egypt IVD Revenue and Growth Rate (2015-2020)

Figure 65. South Africa IVD Revenue and Growth Rate (2015-2020)

Figure 66. Global IVD Revenue Share by Type (2015-2020)

Figure 67. Global IVD Revenue Share by Type in 2019

Figure 68. Global IVD Market Share Forecast by Type (2021-2025)

Figure 69. Global Immuno Diagnostics Revenue Growth Rate (2015-2020)

Figure 70. Global Chemistry Diagnostics Revenue Growth Rate (2015-2020)

Figure 71. Global Molecular Diagnostics Revenue Growth Rate (2015-2020)

Figure 72. Global POCT Revenue Growth Rate (2015-2020)

Figure 73. Global Other Revenue Growth Rate (2015-2020)

Figure 74. Global IVD Revenue Share by Application (2015-2020)

Figure 75. Global IVD Revenue Share by Application in 2019

Figure 76. Global IVD Market Share Forecast by Application (2021-2025)

Figure 77. Global Diabetes Revenue Growth Rate (2015-2020)

Figure 78. Global Infectious Diseases Revenue Growth Rate (2015-2020)

Figure 79. Global Oncology/Cancer Revenue Growth Rate (2015-2020)

Figure 80. Global Cardiology Revenue Growth Rate (2015-2020)

Figure 81. Global Nephrology Revenue Growth Rate (2015-2020)

Figure 82. Global Autoimmune Diseases Revenue Growth Rate (2015-2020)

Figure 83. Global Drug Testing/Pharmacogenomics Revenue Growth Rate (2015-2020)

Figure 84. Global HIV/AIDS Revenue Growth Rate (2015-2020)

Figure 85. Global Others Revenue Growth Rate (2015-2020)

Figure 86. Global IVD Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 87. Global IVD Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 88. Global IVD Revenue Market Share Forecast by Regions (2021-2025)

Figure 89. North America IVD Revenue Market Forecast (2021-2025)

Figure 90. Europe IVD Revenue Market Forecast (2021-2025)

Figure 91. Asia-Pacific IVD Revenue Market Forecast (2021-2025)

Figure 92. South America IVD Revenue Market Forecast (2021-2025)

Figure 93. Middle East and Africa IVD Revenue Market Forecast (2021-2025)

Figure 94. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!